We are a preclinical research-oriented pharmaceutical company that aims to (1) build pipelines of novel drugs and their delivery systems for enhanced therapeutic efficacy and reduced side effects;(2) develop nutrition products to improve therapeutic outcomes; and (3) provide preclinical drug development services for small molecules, peptides, and biologicals to treat various diseases.

Our areas of research and services include pre-formulation and dosage formulation development, in vitro drug metabolism, drug stability, gastro-intestinal permeability, LC-MS/MS bioanalysis method development and validation, in vivo pharmacokinetics (PK), biodistribution and pharmacodynamics (PD), toxicokinetic studies in rodents, and PK/PD modeling and simulation analysis. 

Our History

X Log Pharmaceuticals is a recently established company built on decades of combined experience in academia and industry. Our team has a strong background in pre-clinical studies, supported by numerous publications that showcase our expertise. Recognizing the growing demand for specialized services in both academic research and industry applications, we founded XLog Pharmaceuticals to leverage our extensive knowledge and provide tailored solutions to our clients. Our commitment to excellence positions us to meet the evolving needs of the research community and the pharmaceutical industry